Literature DB >> 21116766

Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.

Amalia Merelli1, Laura Caltana, Patricia Girimonti, Alberto Javier Ramos, Alberto Lazarowski, Alicia Brusco.   

Abstract

Stroke is a major human health problem inducing long-term disability without any efficient therapeutic option being currently available. Under hypoxia, hypoxia-inducible factor-1α (HIF-1α) activates several genes as erythropoietin receptor (Epo-R) related with O(2) supply, and the multidrug-resistance gene (MDR-1) related with drug-refractory phenotype. Brain cortical injection of CoCl(2) produces focal hypoxia-like lesion with neuronal and glial alterations, as well as HIF-1α stabilization and MDR-1 overexpression. Intranasal (IN) drug delivery can by-pass blood-brain barrier (BBB) where MDR-1 is normally expressed. We evaluated the effects of IN-rHu-Epo administration on spontaneous motor activity (SMA) and the brain pattern expression of HIF-1α, MDR-1, and Epo-R in our cobalt-induced hypoxia model. Adult male Wistar rats were injected by stereotaxic surgery in frontoparietal cortex, with CoCl(2) (2 μl-50 mM; n = 20) or saline (controls; n = 20). Ten rats of each group were treated with IN-rHu-Epo 24 U or IN-saline. In addition, erythropoietic stimulation was evaluated by reticulocytes (Ret) account during three consecutive days, after intraperitoneal (i.p.)-recombinant-human Epo (rHu-Epo) (950 U; n = 6) or IN-rHu-Epo (24 U; n = 6) administration. SMA was evaluated by open field and rotarod tests, before and after surgical procedures during five consecutive days. Histological and immunostaining studies of HIF-1α, MDR-1, and Epo-R were performed on brain slides. A significant difference in SMA was observed in the hypoxic rats of IN-rHu-Epo-administered group as compared with Co-Saline-treated subjects and controls (p < 0.001). HIF-1α, EPO-R, and MDR-1 were overexpressed in the hypoxic cortex areas, while in contralateral hemisphere or controls, they were negatives. Reticulocytes were only increased in intraperitoneal (i.p.)-rHu-Epo-administered group. In spite of MDR-1 overexpression being detected in neurons, the coexpression of Epo-R could explain the positive effects observed on SMA of IN-rHu-Epo-administered group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116766     DOI: 10.1007/s12640-010-9233-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  60 in total

1.  HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia.

Authors:  D M Stroka; T Burkhardt; I Desbaillets; R H Wenger; D A Neil; C Bauer; M Gassmann; D Candinas
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

2.  Intranasal insulin improves memory in humans.

Authors:  Christian Benedict; Manfred Hallschmid; Astrid Hatke; Bernd Schultes; Horst L Fehm; Jan Born; Werner Kern
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

Review 3.  Effects of erythropoietin on brain function.

Authors:  W Jelkmann
Journal:  Curr Pharm Biotechnol       Date:  2005-02       Impact factor: 2.837

4.  Ischemic preconditioning in 18- to 20-month-old gerbils: long-term survival with functional outcome measures.

Authors:  J Dowden; D Corbett
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

5.  In vivo expression of mRNAs encoding hypoxia-inducible factor 1.

Authors:  C M Wiener; G Booth; G L Semenza
Journal:  Biochem Biophys Res Commun       Date:  1996-08-14       Impact factor: 3.575

6.  Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells.

Authors:  S Masuda; M Nagao; K Takahata; Y Konishi; F Gallyas; T Tabira; R Sasaki
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

7.  Effects of chronic maternal ethanol exposure on hippocampal and striatal morphology in offspring.

Authors:  Alberto Javier Ramos; Sergio Gustavo Evrard; Patricia Tagliaferro; María Victoria Tricárico; Alicia Brusco
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

8.  The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury.

Authors:  R J Hamm; B R Pike; D M O'Dell; B G Lyeth; L W Jenkins
Journal:  J Neurotrauma       Date:  1994-04       Impact factor: 5.269

Review 9.  Erythropoietin and the brain: from neurodevelopment to neuroprotection.

Authors:  M Buemi; E Cavallaro; F Floccari; A Sturiale; C Aloisi; M Trimarchi; G Grasso; F Corica; N Frisina
Journal:  Clin Sci (Lond)       Date:  2002-09       Impact factor: 6.124

Review 10.  Harnessing hypoxic adaptation to prevent, treat, and repair stroke.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Natalya Smirnova; Ksenia Karpisheva; Renee Haskew-Layton; Stephen McConoughey; Brett Langley; Alvaro Estevez; Patricio T Huerta; Bruce Volpe; Sashwati Roy; Chandan K Sen; Irina Gazaryan; Sunghee Cho; Matthew Fink; Joseph LaManna
Journal:  J Mol Med (Berl)       Date:  2007-11-28       Impact factor: 4.599

View more
  10 in total

1.  Pigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction.

Authors:  Shu-Wei Tian; Yuan Ren; Jin-Zhi Pei; Bai-Chao Ren; Yuan He
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

2.  Hypoxia induces apoptosis and autophagic cell death in human periodontal ligament cells through HIF-1α pathway.

Authors:  Z-C Song; W Zhou; R Shu; J Ni
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

3.  Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats.

Authors:  R J Macias-Velez; L Fukushima-Díaz de León; C Beas-Zárate; M C Rivera-Cervantes
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

4.  Intranasal injection of recombinant human erythropoietin improves cognitive and visual impairments in chronic cerebral ischemia rats.

Authors:  Yanhui Zhou; Bin Sun; Junhong Guo; Guohong Zhou
Journal:  Biomed Rep       Date:  2020-08-25

5.  Pilocarpine-Induced Status Epilepticus Is Associated with P-Glycoprotein Induction in Cardiomyocytes, Electrocardiographic Changes, and Sudden Death.

Authors:  Jerónimo Auzmendi; Bruno Buchholz; Jimena Salguero; Carlos Cañellas; Jazmín Kelly; Paula Men; Marcela Zubillaga; Alicia Rossi; Amalia Merelli; Ricardo J Gelpi; Alberto J Ramos; Alberto Lazarowski
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-16

6.  Inhibition of autophagy enhanced cobalt chloride‑induced apoptosis in rat alveolar type II epithelial cells.

Authors:  Yan Yu; Wanting Li; Liqin Ren; Chunyan Yang; Dongze Li; Xin Han; Yeying Sun; Changjun Lv; Fang Han
Journal:  Mol Med Rep       Date:  2018-06-22       Impact factor: 2.952

Review 7.  Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?

Authors:  Sara Ottolenghi; Giuseppina Milano; Michele Dei Cas; Tina O Findley; Rita Paroni; Antonio F Corno
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

Review 8.  The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review.

Authors:  Yuanyuan Ma; Zhiyuan Zhou; Guo-Yuan Yang; Jing Ding; Xin Wang
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

Review 9.  Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?

Authors:  Liliana Czornyj; Jerónimo Auzmendi; Alberto Lazarowski
Journal:  Epilepsia Open       Date:  2021-10-29

10.  Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.

Authors:  Orestes Santos-Morales; Alina Díaz-Machado; Daise Jiménez-Rodríguez; Yaisel Pomares-Iturralde; Tatiana Festary-Casanovas; Carlos A González-Delgado; Sonia Pérez-Rodríguez; Eulalia Alfonso-Muñoz; Carmen Viada-González; Patricia Piedra-Sierra; Idrian García-García; Daniel Amaro-González; Julio César García-Rodríguez; Iliana Sosa-Testé; Alicia Lagarto-Parra; Laura Barrero-Viera; Marlene David-Baldo; Maura Tamayo-Rodríguez; Ivonne Rivero-Vázquez; Gricel González-Gamiz; Alis Martín-Trujillo; Yasmila Rodríguez-Fernández; Ana Alfa Ledo-de la Luz; Maylén Álvarez-Delgado; Ivón Howland-Álvarez; Yolanda Cruz-Gómez
Journal:  BMC Neurol       Date:  2017-07-04       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.